Giancarlo Icardi

Giancarlo Icardi publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Giancarlo Icardi sits on this spectrum.

Giancarlo Icardi D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Giancarlo Icardi sits on this spectrum.

Best Publications

• Bloodstream infections in critically ill patients with COVID-19.

  Daniele Roberto Giacobbe;Denise Battaglini;Lorenzo Ball;Iole Brunetti

  294
  Citations

• Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study.

  Robert Arnou;Giancarlo Icardi;Marijke de Decker;Arvydas Ambrozaitis

  242
  Citations

• Different seroprevalence and molecular epidemiology patterns of hepatitis C virus infection in Italy

  Unknown

  213
  Citations

• Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies.

  Maria Pia Sormani;Matilde Inglese;Irene Schiavetti;Luca Carmisciano

  212
  Citations

• Assessing Ebola-related web search behaviour: insights and implications from an analytical study of Google Trends-based query volumes

  Cristiano Alicino;Nicola Luigi Bragazzi;Valeria Faccio;Daniela Amicizia

  171
  Citations

• Cross-protection by MF59-adjuvanted influenza vaccine: neutralizing and haemagglutination-inhibiting antibody activity against A(H3N2) drifted influenza viruses.

  Filippo Ansaldi;Sabrina Bacilieri;Paolo Durando;Laura Sticchi

  146
  Citations

• Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy

  Unknown

  143
  Citations

• Antibody response against heterogeneous circulating influenza virus strains elicited by MF59- and non-adjuvanted vaccines during seasons with good or partial matching between vaccine strain and clinical isolates.

  Filippo Ansaldi;Marta Zancolli;Paolo Durando;Emanuele Montomoli

  134
  Citations

• A Randomized, Double-Blind, Phase III Study of the Immunogenicity and Safety of a 9-Valent Human Papillomavirus L1 Virus-Like Particle Vaccine (V503) Versus Gardasil® in 9-15-Year-Old Girls

  Timo Vesikari;Nicholas Brodszki;Pierre van Damme;Javier Diez-Domingo

  134
  Citations

• Novel Approach To Reduce the Hepatitis C Virus (HCV) Window Period: Clinical Evaluation of a New Enzyme-Linked Immunosorbent Assay for HCV Core Antigen

  Unknown

  130
  Citations

• Tocilizumab and steroid treatment in patients with COVID-19 pneumonia.

  Malgorzata Mikulska;Laura Ambra Nicolini;Alessio Signori;Antonio Di Biagio

  119
  Citations

• Impaired Response to Influenza Vaccine Associated with Persistent Memory B Cell Depletion in Non-Hodgkin’s Lymphoma Patients Treated with Rituximab-Containing Regimens

  Davide Bedognetti;Gabriele Zoppoli;Gabriele Zoppoli;Carlotta Massucco;Elisa Zanardi;Elisa Zanardi

  114
  Citations

• Safety and Immunogenicity of Two Influenza Virus Subunit Vaccines, with or without MF59 Adjuvant, Administered to Human Immunodeficiency Virus Type 1-Seropositive and -Seronegative Adults

  P. Durando;D. Fenoglio;A. Boschini;F. Ansaldi

  99
  Citations

• MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk

  Unknown

  96
  Citations

• Influenza and pneumococcal vaccinations of patients with systemic lupus erythematosus: current views upon safety and immunogenicity.

  Giuseppe Murdaca;Andrea Orsi;Francesca Spanò;Francesco Puppo

  92
  Citations

• Leptin has no role in determining severity of steatosis and fibrosis in patients with chronic hepatitis C

  Edoardo Giannini;Paola Ceppa;Federica Botta;Luca Mastracci

  92
  Citations

• Vaccination coverage in healthcare workers: a multicenter cross-sectional study in Italy

  C Genovese;I A M Picerno;G Trimarchi;G Cannavò

  91
  Citations

• The Adjuvanted Recombinant Zoster Vaccine Confers Long-term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase III Clinical Trials (ZOE-50 and ZOE-70).

  Céline Boutry;Andrew Hastie;Javier Diez-Domingo;Juan Carlos Tinoco

  89
  Citations

• Adjuvants and alternative routes of administration towards the development of the ideal influenza vaccine.

  Unknown

  84
  Citations

• The impact of 10-valent and 13-valent pneumococcal conjugate vaccines on hospitalization for pneumonia in children: A systematic review and meta-analysis

  Unknown

  84
  Citations